Medicine
Selzentry 150 mg tablet
Selzentry 150 mg tablet is a prescription medicine containing Maraviroc for oral use, marketed by ViiV Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
SELZENTRY film-coated tablets should be stored at 20 • C to 25 • C (68 • F to…
Key facts
- Active ingredient (INN)
- Maraviroc
- Brand
- Selzentry
- Strength
- 150 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets
- Marketing authorisation holder
- ViiV Healthcare
- Manufacturers
- ViiV HealthcareA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- SELZENTRY film-coated tablets should be stored at 20 • C to 25 • C (68 • F to 77 • F), excursions permitted between 15 • C and 30 • C (59 • F and 86 • F). SELZENTRY oral solution should be stored at 20 • C to 25 • C (68 • F to 77 • F), excursions permitted between 15 • C and 30 • C (59 • F and 86 • F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AX09 Maraviroc
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 May 2011
- Identifiers
- RxCUI 728223, 728225, 729201 +3DailyMed set ID 46f30ac5-c96b-429e-976d-8c5ee1c0761b, 3c52dddd-0457-41cd-99e0-d30d4fd00ec5NDC 49702-223, 50090-6238Application NDA022128
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet, film coated in 1 bottle | 49702-223-18 | ViiV Healthcare | 16 May 2011 |
| 60 tablet, film coated in 1 bottle | 50090-6238-0 | A-S Medication Solutions | 29 November 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Maraviroc 150 mg tablet.
Other strengths and forms of Maraviroc
Clinical summary
Maraviroc is a CCR5 Co-receptor antagonist indicated in combination with other antiretroviral agents for the treatment of only CCR5-tropic human immunodeficiency virus type 1 (HIV-1) infection in adult and pediatric patients weighing at least 2 kg. MedsAcross supplies Maraviroc for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MaravirocFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SELZENTRY prescribing information (ViiV Healthcare) · U.S. National Library of Medicine, DailyMed
- Celsentri: European public assessment report (EPAR) · European Medicines Agency
Need Selzentry 150 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.